Kinetics of Anti-Sars-Cov-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health Workers

Mostrar otras versiones (1)

Background: Levels of neutralizing antibodies (NΑbs) against SARS-CoV-2 correlate with clinically relevant immune protection from COVID-19. However, a slight decline in antibody titers has become evident even at one month following the second BNT162b2 shot, whereas increased time since the second va...

Descripción completa

Detalles Bibliográficos
Autores principales: Terpos, Evangelos, Trougakos, Ioannis P., Karalis, Vangelis, Ntanasis-Stathopoulos, Ioannis, Apostolakou, Filia, Gumeni, Sentiljana, Sklirou, Aimilia D., Skourti, Stamatia, Gavriatopoulou, Maria, Kastritis, Efstathios, Korompoki, Eleni, Papassotiriou, Ioannis, Dimopoulos, Meletios A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
203.Lymphocytes and Acquired or Congenital Immunodeficiency Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701429/
http://dx.doi.org/10.1182/blood-2021-145074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701429/
http://dx.doi.org/10.1182/blood-2021-145074

Ejemplares similares